Dow Jones (DJIA) Today: Chevron (CVX) Leads The Day Higher, Merck (MRK) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer..

The Dow Jones Industrial Average ( ^DJI) is trading down 88.0 points (-0.5%) at 17,952 as of Tuesday, Jun 2, 2015, 9:36 a.m. ET. During this time, 20.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 359.8 million. The NYSE advances/declines ratio sits at 865 issues advancing vs. 1,890 declining with 225 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Chevron (NYSE: CVX), which is sporting a seven-cent gain to $102.70. Volume for Chevron currently sits at 203,125 shares traded vs. an average daily trading volume of 6.9 million shares.

Chevron has a market cap of $193.69 billion and is part of the basic materials sector and energy industry. Shares are down 8.5% year-to-date as of Monday's close. The stock's dividend yield sits at 4.2%.

Chevron Corporation, through its subsidiaries, engages in the petroleum, chemicals, and power and energy operations worldwide. The company operates in two segments, Upstream and Downstream.

TheStreet Ratings rates Chevron as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity.

Holding back the Dow today is Merck (NYSE: MRK), which is lagging the broader Dow index with an 81-cent decline (-1.3%) bringing the stock to $59.94. This single loss is lowering the Dow Jones Industrial Average by 6.13 points or roughly accounting for 7% of the Dow's overall loss. Volume for Merck currently sits at 598,837 shares traded vs. an average daily trading volume of 11.5 million shares.

Merck has a market cap of $172.03 billion and is part of the health care sector and drugs industry. Shares are up 7% year-to-date as of Monday's close. The stock's dividend yield sits at 3%.

Merck & Co., Inc. provides health care solutions worldwide.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE..

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again